Global Viral Clearance Market By Overview
Introduction:
Viral Clearance Market was valued at US$ 711.7 Million in 2024 and is projected to grow at a CAGR of 17.0% to reach US$ 2984.3 Million by 2034.
Virus elimination and inactivation continue to emerge as an important factor in overall bioprocess safety. As bioprocesses, Methods, and unit operations flourish, viral clearance will become more customized to industrial and individual situations. At the same time, the global viral clearance market will keep extending its purview. Viral clearance is also called viral safety. For example, in case of inactivation of reagents such as monoclonal antibodies and recombinant proteins, companies, CROs, and diagnostic testing labs need to evaluate the removal of specific viral strains or viral copy number in samples.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Viral Clearance Market By Dynamics
Increasing demand in pharmaceutical and biotechnological industries
The major driver of the global viral clearance market is increasing demand in the pharmaceutical and biotechnological industries and the vast rise in R&D. Rise in the number of new drug launches in various segments and associated drug approval processes are also boosting the target market growth. However, high degree of consolidation act is going to restrain the growth of the target market over the forecast period. Viruses can seriously infect all types of life forms from a bacterium to archaea and also animals and plants to microorganisms. Viruses also have the ability of infect bacterial cells. The target market is also expected to benefit by the vast rise in funding from government, public, and private bodies towards the pharmaceutical industry with the aim of developing effective cure for the vast number of chronic diseases affecting the global population. The global market has wide opportunities for the key applications of viral clearance, including blood and blood methods, gene and cellular therapy methods, tissue and associated methods, vaccine and therapeutics, and stem cell methods.
Global Viral Clearance Market By Segmentation
The viral clearance market is segmented based on method, application, end user, and region.
Based on method, the global viral clearance market is segmented into viral removal and viral inactivation. Viral removal segment is expected to holds largest market over the forecast period due to rising biopharmaceutical R&D activities. Based on application, the target market is bifurcated into recombinant proteins, tissue and blood derived methods, vaccines, others. Recombinant proteins are estimated to holds largest share of market over the forecast period due to it has huge potential to treat various diseases, tiny side effects, and it takes less time for the development. Based on the end user, the target market is segmented into biopharmaceuticals, contract research organizations, and academic research institutes. Pharmaceutical & biotechnology companies are expected to share largest market of viral clearance during forecast period.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Based on the region the global viral clearance market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global viral clearance market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific viral clearance market is projected to register a high CAGR over the forecast period owing to the growing trend of emphasis on quality assurance and quality control departments in the industries boost the growth of the global virus clearance market.
Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 711.7 million |
|
Projected Market Size 2034 |
US$ 2984.3 million |
|
CAGR Growth Rate |
17% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Method - Viral Removal and Viral Inactivation By Application - Recombinant Proteins, Tissue and Blood Derived Methods, Vaccines, and Others By End-User - Biopharmaceuticals, Contract Research Organizations, and Academic Research Institutes
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Viral Clearance Market, By Method:
- Viral Removal
- Viral Inactivation
Viral Clearance Market, By Application:
- Recombinant Proteins
- Tissue and Blood Derived Methods
- Vaccines
- Others
Viral Clearance Market, By End User:
- Biopharmaceuticals
- Contract Research Organizations
- Academic Research Institutes
Viral Clearance Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Viral Clearance Market, By Method
- Middle East & Africa Viral Clearance Market, By Application
- Middle East & Africa Viral Clearance Market, By End User
- Middle East & Africa Viral Clearance Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Viral Clearance Market, By Method
- Latin America Viral Clearance Market, By Application
- Latin America Viral Clearance Market, By End User
- Latin America Viral Clearance Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Viral Clearance Market, By Method
- Asia Pacific Viral Clearance Market, By Application
- Asia Pacific Viral Clearance Market, By End User
- Asia Pacific Viral Clearance Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Viral Clearance Market, By Method
- Europe Viral Clearance Market, By Application
- Europe Viral Clearance Market, By End user
- Europe Viral Clearance Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Viral Clearance Market, By Method
- North America Viral Clearance Market, By Application
- North America Viral Clearance Market, By End User
- North America Viral Clearance Market, By Country
- The U.S.
- Canada
- Middle East & Africa
Global Viral Clearance Market By Key Players
The key players operating the viral clearance market involves Charles River, Labor Dr. Merk & Kollegen GmbH, Texcell, Merck KGaA, WuXi AppTec, Sartorius AG, Eurofins Scientific, Bioscience Laboratories, Syngene, Vironova, Sigma-Aldrich Corporation. Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), these companies together accounted for 70.0% of the global viral clearance market in 2017
Global Viral Clearance Market By Company Profile
- Charles River
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Labor Dr. Merk & Kollegen GmbH
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Texcell
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Merck KGaA
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- WuXi AppTec
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Sartorius AG
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Eurofins Scientific
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Bioscience Laboratories
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Syngene
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Vironova
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Sigma-Aldrich Corporation
- Company Overview
- Financial Performance
- Key Highlights
- Product Portfolio
Global Viral Clearance Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Viral Clearance Strategies
- Key Questions this Study will Answer
- Market Snippet, By Method
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Method, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Viral Removal
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Viral Inactivation
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Recombinant Proteins
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Tissue and Blood Derived Methods
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Vaccines
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By End User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Biopharmaceuticals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Contract Research Organizations
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Academic Research Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Method, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Method, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Method, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Method, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Method, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Charles River
- Financial Overview
- Key Highlights
- Product Portfolio
- Company Overview
- Labor Dr. Merk & Kollegen GmbH
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Texcell
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Merck KGaA
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- WuXi AppTec
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Sartorius AG
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Bioscience Laboratories
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Syngene; Vironova
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
- Sigma-Aldrich Corporation
- Company Overview
- Financial Overview
- Key Highlights
- Product Portfolio
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The viral clearance market is segmented based on method, application, end user, and region
The major driver of the global viral clearance market is increasing demand in the pharmaceutical and biotechnological industries and the vast rise in R&D.
The market in North America accounts highest revenue share to the global viral clearance market due to growing demand for advanced medical technologies and increasing geriatric population.
The key players operating the viral clearance market involves Charles River, Labor Dr. Merk & Kollegen GmbH, Texcell, Merck KGaA, WuXi AppTec, Sartorius AG, Eurofins Scientific, Bioscience Laboratories, Syngene, Vironova, Sigma-Aldrich Corporation.